(CRD-A) Crawford & - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246332066

CRD-A: Claims Management, Outsourcing Solutions, Loss Adjusting, Claims Adjusting

Crawford & Company (NYSE:CRD-A) is a global provider of claims management and outsourcing solutions, operating across the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The company specializes in risk management services for insurance carriers, brokers, and corporations, offering tailored solutions for property, liability, automobile, marine, workers compensation, and disability claims. Its North America Loss Adjusting segment focuses on claims management for property, public liability, automobile liability, and marine insurances, serving both insurance carriers and self-insured entities. The International Operations segment extends similar services globally, emphasizing field investigations, property and casualty claim evaluation, and resolution. The Broadspire segment provides comprehensive claims management, including workers compensation, liability, and accident and health claims, alongside disability and leave management, legal services, and risk management analytics. This segment also offers medical management, administration, and physician review services, as well as claims and risk management technology solutions. The Platform Solutions segment delivers managed repair and outsourced contractor management services, specializing in natural disasters like hurricanes, earthquakes, and floods, as well as man-made disasters such as oil spills and explosions. Additionally, this segment provides outsourced subrogation claims management and recovery services for the property and casualty insurance industry. Founded in 1941 and headquartered in Atlanta, Georgia, Crawford & Company has established itself as a key player in the insurance services sector.

Based on the provided and , Crawford & Companys stock (CRD-A) is expected to remain stable over the next three months. The SMA 20 of 12.02 and SMA 50 of 11.66 suggest a neutral to slightly bullish short-term trend, with the stock trading near its 20-day moving average. The ATR of 0.49 indicates moderate volatility, with potential price swings limited to a range of $11.59 to $12.57. Fundamentally, the companys P/E of 30.05 reflects high market expectations, while the forward P/E of 11.67 signals potential undervaluation. The P/S ratio of 0.47 suggests the stock may be undervalued relative to its revenue generation. Overall, the stock is likely to experience sideways movement with limited upside, driven by its current valuation metrics and technical indicators.

Additional Sources for CRD-A Stock

CRD-A Stock Overview

Market Cap in USD 496m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1992-03-19

CRD-A Stock Ratings

Growth Rating 52.8
Fundamental 31.2
Dividend Rating 62.6
Rel. Strength -2.98
Analysts 4/5
Fair Price Momentum 10.23 USD
Fair Price DCF 7.12 USD

CRD-A Dividends

Dividend Yield 12m 2.61%
Yield on Cost 5y 4.26%
Annual Growth 5y 8.06%
Payout Consistency 81.1%

CRD-A Growth Ratios

Growth Correlation 3m -82.3%
Growth Correlation 12m 73.3%
Growth Correlation 5y 66.3%
CAGR 5y 10.36%
CAGR/Max DD 5y 0.20
Sharpe Ratio 12m 0.47
Alpha 4.43
Beta 1.084
Volatility 35.87%
Current Volume 34.9k
Average Volume 20d 71.7k
What is the price of CRD-A stocks?
As of April 26, 2025, the stock is trading at USD 10.78 with a total of 34,898 shares traded.
Over the past week, the price has changed by +5.48%, over one month by -5.19%, over three months by -7.95% and over the past year by +15.74%.
Is Crawford & a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Crawford & is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.21 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRD-A as of April 2025 is 10.23. This means that CRD-A is currently overvalued and has a potential downside of -5.1%.
Is CRD-A a buy, sell or hold?
Crawford & has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CRD-A.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CRD-A stock price target?
According to ValueRays Forecast Model, CRD-A Crawford & will be worth about 11.3 in April 2026. The stock is currently trading at 10.78. This means that the stock has a potential upside of +4.64%.
Issuer Forecast Upside
Wallstreet Target Price 14 29.9%
Analysts Target Price 14 29.9%
ValueRay Target Price 11.3 4.6%